Biological Coprocessors (a Q-Bank Group company) is conducting technology research and development to commercialize analytical applications that detect brain pathology and augment performance in healthy and diseased people. Currently the firm is working with collaborators globally on a variety of novel neuro-technology product research and development activities, ranging from non-invasive diagnostic solutions to novel clinical treatments. In collaboration with the University of Oxford in the U.K., principals have identified an objective brain wave signature for pain patients. Work is currently underway to validate the detection of the signature using low cost, non-invasive methods of measuring brain wave patterns. Additionally, staff are testing the viability of Transcranial Direct Current Stimulation (tDCS) to manage and reduce the pain level by normalizing the defective brain wave patterns. Also working on diagnostic and treatment tools for a range of other brain-related ailments including PTSD, Alzheimer's disease, Parkinson's disease, and others.
